DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
Key takeaways
- Dex Com Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day Market Beat Sat, May 16, 2026 at 8:08 PM GMT+7 8 min read DXCM Key Points Interested in Dex Com, Inc.?
- Dex Com outlined a long-term growth plan targeting more than 10% annual revenue growth through 2030, along with margin expansion and stronger cash flow.
- Product development is centered on G7 15 Day and next-generation G8, with G7 15 Day rolling out in the U.S. and internationally later this year.
Dex Com Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day Market Beat Sat, May 16, 2026 at 8:08 PM GMT+7 8 min read DXCM Key Points Interested in Dex Com, Inc.? Here are five stocks we like better.
Dex Com outlined a long-term growth plan targeting more than 10% annual revenue growth through 2030, along with margin expansion and stronger cash flow. Management also said it plans to repurchase $1 billion of stock in 2026 and return at least 50% of annual free cash flow to buybacks going forward.
Product development is centered on G7 15 Day and next-generation G8, with G7 15 Day rolling out in the U.S. and internationally later this year. DexCom said G8 could launch around late 2027 or early 2028 and is designed to be 50% smaller, more accurate, and lower cost to make than G7.